156 related articles for article (PubMed ID: 38244067)
1. Antimicrobial prophylaxis for vesicoureteral reflux: which subgroups of children benefit the most?
Zhao B; Ivanova A; Shaikh N
Pediatr Nephrol; 2024 Jun; 39(6):1859-1863. PubMed ID: 38244067
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial prophylaxis for vesicoureteral reflux: which subgroups of children benefit the most?
Zhao B; Ivanova A; Shaikh N
Res Sq; 2023 Aug; ():. PubMed ID: 37693511
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.
Keren R; Shaikh N; Pohl H; Gravens-Mueller L; Ivanova A; Zaoutis L; Patel M; deBerardinis R; Parker A; Bhatnagar S; Haralam MA; Pope M; Kearney D; Sprague B; Barrera R; Viteri B; Egigueron M; Shah N; Hoberman A
Pediatrics; 2015 Jul; 136(1):e13-21. PubMed ID: 26055855
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Urinary Tract Infections in Children With Bladder and Bowel Dysfunction.
Shaikh N; Hoberman A; Keren R; Gotman N; Docimo SG; Mathews R; Bhatnagar S; Ivanova A; Mattoo TK; Moxey-Mims M; Carpenter MA; Pohl HG; Greenfield S
Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26647376
[TBL] [Abstract][Full Text] [Related]
5. Update and Summary of the European Association of Urology/European Society of Paediatric Urology Paediatric Guidelines on Vesicoureteral Reflux in Children.
Gnech M; 't Hoen L; Zachou A; Bogaert G; Castagnetti M; O'Kelly F; Quaedackers J; Rawashdeh YF; Silay MS; Kennedy U; Skott M; van Uitert A; Yuan Y; Radmayr C; Burgu B
Eur Urol; 2024 May; 85(5):433-442. PubMed ID: 38182493
[TBL] [Abstract][Full Text] [Related]
6. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.
Mattoo TK; Chesney RW; Greenfield SP; Hoberman A; Keren R; Mathews R; Gravens-Mueller L; Ivanova A; Carpenter MA; Moxey-Mims M; Majd M; Ziessman HA;
Clin J Am Soc Nephrol; 2016 Jan; 11(1):54-61. PubMed ID: 26555605
[TBL] [Abstract][Full Text] [Related]
7. The RIVUR trial: a factual interpretation of our data.
Mattoo TK; Carpenter MA; Moxey-Mims M; Chesney RW;
Pediatr Nephrol; 2015 May; 30(5):707-12. PubMed ID: 25558811
[TBL] [Abstract][Full Text] [Related]
8. Computer model predicting breakthrough febrile urinary tract infection in children with primary vesicoureteral reflux.
Arlen AM; Alexander SE; Wald M; Cooper CS
J Pediatr Urol; 2016 Oct; 12(5):288.e1-288.e5. PubMed ID: 27072485
[TBL] [Abstract][Full Text] [Related]
9. The Swedish infant high-grade reflux trial: UTI and renal damage.
Nordenström J; Sjöström S; Sillén U; Sixt R; Brandström P
J Pediatr Urol; 2017 Apr; 13(2):146-154. PubMed ID: 28215835
[TBL] [Abstract][Full Text] [Related]
10. The Swedish infant high-grade reflux trial: Study presentation and vesicoureteral reflux outcome.
Nordenström J; Holmdahl G; Brandström P; Sixt R; Stokland E; Sillén U; Sjöström S
J Pediatr Urol; 2017 Apr; 13(2):130-138. PubMed ID: 27889221
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based clinical practice guideline for management of urinary tract infection and primary vesicoureteric reflux.
Hari P; Meena J; Kumar M; Sinha A; Thergaonkar RW; Iyengar A; Khandelwal P; Ekambaram S; Pais P; Sharma J; Kanitkar M; Bagga A;
Pediatr Nephrol; 2024 May; 39(5):1639-1668. PubMed ID: 37897526
[TBL] [Abstract][Full Text] [Related]
12. Sonographic assessment of the effect of vesicoureteral reflux and urinary tract infections on growth of the pediatric solitary kidney.
Ross I; Ahn HJ; Roelof B; Barber T; Huynh V; Rockette A; Popovic M; Chen JJ; Steinhardt G
J Pediatr Urol; 2015 Jun; 11(3):145.e1-6. PubMed ID: 25864614
[TBL] [Abstract][Full Text] [Related]
13. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.
Carpenter MA; Hoberman A; Mattoo TK; Mathews R; Keren R; Chesney RW; Moxey-Mims M; Greenfield SP;
Pediatrics; 2013 Jul; 132(1):e34-45. PubMed ID: 23753091
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal follow-up of bladder function in children who participated in the Swedish Reflux Trial.
Sillen U; Hansson S; Jernmark S; Sjöström S; Brandström P
J Pediatr Urol; 2024 Feb; 20(1):118-126. PubMed ID: 37684195
[TBL] [Abstract][Full Text] [Related]
15. Asian guidelines for urinary tract infection in children.
Yang SS; Tsai JD; Kanematsu A; Han CH
J Infect Chemother; 2021 Nov; 27(11):1543-1554. PubMed ID: 34391623
[TBL] [Abstract][Full Text] [Related]
16. The RiVUR Study Outcomes and Implications on the Management of Vesicoureteral Reflux.
Damm T; Mathews R
Arch Nephrol Ren Stud; 2022; 2(1):1-5. PubMed ID: 35928985
[TBL] [Abstract][Full Text] [Related]
17. The role of antimicrobial prophylaxis in the management of children with vesicoureteral reflux--the RIVUR study outcomes.
Mathews R; Mattoo TK
Adv Chronic Kidney Dis; 2015 Jul; 22(4):325-30. PubMed ID: 26088078
[TBL] [Abstract][Full Text] [Related]
18. Vesicoureteral reflux and continuous prophylactic antibiotics.
Lee T; Park JM
Investig Clin Urol; 2017 Jun; 58(Suppl 1):S32-S37. PubMed ID: 28612058
[TBL] [Abstract][Full Text] [Related]
19. Bladder/bowel dysfunction in pre-school children following febrile urinary tract infection in infancy.
Sjöström S; Sillén U; Bachelard M; Johansson E; Brandström P; Hellström AL; Abrahamsson K
Pediatr Nephrol; 2021 Jun; 36(6):1489-1497. PubMed ID: 33274398
[TBL] [Abstract][Full Text] [Related]
20. Long-term, low-dose prophylaxis against urinary tract infections in young children.
Brandström P; Hansson S
Pediatr Nephrol; 2015 Mar; 30(3):425-32. PubMed ID: 24906665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
